Identification |
Name: | 1H-Indeno[5,4-f]quinoline-7-carboxylicacid,2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-,(4aR,4bS,6aS,7S,9aS,9bS,11aR)- |
Synonyms: | 4-Azaandrost-1-ene-17-carboxylicacid, 3-oxo-, (5a,17b)-;1H-Indeno[5,4-f]quinoline-7-carboxylic acid,2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-,[4aR-(4aa,4bb,6aa,7a,9ab,9ba,11ab)]-; |
CAS: | 104239-97-6 |
Molecular Formula: | C19H27NO3 |
Molecular Weight: | 317.42 |
InChI: | InChI=1/C19H27NO3/c1-18-9-7-13-11(12(18)4-5-14(18)17(22)23)3-6-15-19(13,2)10-8-16(21)20-15/h8,10-15H,3-7,9H2,1-2H3,(H,20,21)(H,22,23)/t11-,12-,13-,14+,15+,18-,19+/m0/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 295-297 ºC |
Density: | 1.166 |
Refractive index: | 1.547 |
Appearance: | off-white powder |
Usage: | An intermediate in the synthesis of Finasteride, am onhibitor of 5a-reductase, the enzyme which converts testosterone to the more potent androgen, 5a-dihydrotestosterone |
Safety Data |
|
|